This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
  • Home
  • /
  • Drugs
  • /
  • G
  • /
  • Granisol
  • /
  • Granisol GRANISETRON HYDROCHLORIDE 2 mg/10mL Intra-Sana Laboratories
FDA Drug information

Granisol

Read time: 1 mins
Marketing start date: 01 Aug 2025

Summary of product characteristics


Application Number

ANDA219282

Brand Name

Granisol

Generic Name

granisetron hydrochloride

Product Ndc

80056-801

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.